Molecular Sensing
Dr. Rich has over 30 years experience in research, marketing, and general management in the instrumentation field. He is a founder, and retired CEO/President of Ciphergen Biosystems. He was CEO/President of BioSepra, SVP of Sepracor, and SVP of Dionex, as a member of the founding team. Dr. Rich received his PhD in chemistry from the University of North Carolina, Chapel Hill and completed post-doctoral work at Duke University in biochemistry. He completed the Executive Management Program at Stanford University. He holds a number of patents related to bioanalytical instrumentation
This person is not in any offices
Molecular Sensing
Molecular Sensing, Inc. (MSI) is commercializing Back-Scattering Interferometry (BSI), the world’s first label-free, conformation-sensitive.